IDiyas

For the Inventor, By the Inventor

Chengdu, China

Jing Wang

USPTO Granted Patents = 24 

 

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 24(Granted Patents)


Location History:

  • Nanjing, CN (2014 - 2020)
  • Shen Zhen, CN (2007 - 2023)
  • Chengdu, CN (2015 - 2024)
  • Sichuan, CN (2024)

Company Filing History:

goldMedal8 out of 27,108 
 
Huawei Technologies Co., Limited
 patents
silverMedal5 out of 7,353 
 
Emc IP Holding Company LLC
 patents
bronzeMedal3 out of 26 
 
Sichuan Kelun-biotech Biopharmaceutical Co., Ltd.
 patents
4. 2 out of 31 
 
Amphenol Commercial Products (chengdu) Co.ltd
 patents
5. 2 out of 2,209 
 
Motorola Solutions, Inc.
 patents
6. 2 out of 5 
 
Institute of Chemical Industry of Forest Products, Caf
 patents
7. 1 out of 30,028 
 
Siemens Aktiengesellschaft
 patents
8. 1 out of 832,680 
Other
 patents

Years Active: 2007-2024

where 'Filed Patents' based on already Granted Patents

24 patents (USPTO):
1. 12150944 - Use of anti-HER2 antibody-drug conjugate in cancer treatment (2024-11-26),
2. 11940782 - Product performance prediction modeling to predict final product performance in case of device exception (2024-03-26),
3. D1017823 - Rubik's cube male masturbator (2024-03-12),
4. 11903948 - Anti-ErbB2 antibody-drug conjugate and composition thereof, preparation method therefor, and use thereof (2024-02-20),
5. 11824305 - Robust and reliable high speed electrical connector assembly (2023-11-21),
6. 11817639 - Miniaturized electrical connector for compact electronic system (2023-11-14),
7. 11770865 - Relay communication method and relay communications apparatus and system (2023-09-26),
8. 11740955 - Method, electronic device, and computer program product for extracting fault information from log files (2023-08-29),
9. 11487629 - Method, device and computer program product for managing data backup (2022-11-01),
10. 11340953 - Method, electronic device and computer program product for load balance (2022-05-24),
11. 11301337 - Method, device, and computer program product for managing backup system (2022-04-12),
12. 11294774 - Method for managing backup data on first, second, or third virtual machine management platform (2022-04-05),
13. 11207420 - Cytotoxin and conjugate, uses of same and preparation method therefor (2021-12-28),
14. 10674723 - 1,8-bis(Schiff base)-p-menthane derivatives as well as preparation method and applications thereof (2020-06-09),
15. 10469996 - Group scan in overlapping geofences (2019-11-05),

Title: Unveiling the Innovator: Jing Wang, Pioneer in Biopharmaceutical Inventions

Introduction: Jing Wang, a distinguished inventor hailing from Sichuan, China, has left an indelible mark in the field of biopharmaceuticals with his groundbreaking patents and contributions.

Latest Patents: With an impressive portfolio of 2 patents to his name, one notable invention is the "Anti-ErbB2 antibody-drug conjugate and composition thereof." This patent describes a novel preparation method for an antibody-drug conjugate, showcasing Wang's ingenuity and expertise in the biopharmaceutical domain.

Career Highlights: Currently employed at Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., Jing Wang plays a pivotal role in driving innovation and research within the company. His dedication to advancing biopharmaceutical technologies has led to significant advancements in the industry.

Collaborations: Wang's collaborative spirit shines through his work with esteemed colleagues such as Tongtong Xue and Zhenwei Miao. Together, they have synergized their diverse skill sets to propel innovative projects forward, setting new standards in biopharmaceutical research.

Conclusion: Jing Wang stands as a beacon of inspiration in the realm of biopharmaceutical inventions, showcasing a relentless pursuit of innovation and excellence. His patents and collaborations underscore his remarkable contributions to the field, cementing his legacy as a visionary inventor shaping the future of biopharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…